PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-06-04
DOI
10.3389/fonc.2019.00462
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C
- (2019) Brandon M. D'Arcy et al. MOLECULAR CANCER THERAPEUTICS
- The NMR-based characterization of the FTY720-SET complex reveals an alternative mechanism for the attenuation of the inhibitory SET-PP2A interaction
- (2019) Ryan M. De Palma et al. FASEB JOURNAL
- Physiologic functions of PP2A: Lessons from genetically modified mice
- (2018) Sara Reynhout et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers
- (2018) Ashton C. Berger et al. CANCER CELL
- Small-Molecule Activators of Protein Phosphatase 2A for the Treatment of Castration-Resistant Prostate Cancer
- (2018) Kimberly McClinch et al. CANCER RESEARCH
- Comprehensive Characterization of Cancer Driver Genes and Mutations
- (2018) Matthew H. Bailey et al. CELL
- Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: A NCI clinical trials planning meeting report
- (2018) Stephanie Lheureux et al. GYNECOLOGIC ONCOLOGY
- Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification
- (2018) Bob Meeusen et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Phosphatases catching up with the level of knowledge: Finally druggable?
- (2018) Jukka Westermarck INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Non-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancer
- (2018) Otto Kauko et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Therapeutic targeting of PP2A
- (2018) Caitlin M. O’Connor et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- CIP2A facilitates the G1/S cell cycle transition via B-Myb in human papillomavirus 16 oncoprotein E6-expressing cells
- (2018) Yonghao Tian et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- CIP2A is overexpressed in human endometrioid adenocarcinoma and regulates cell proliferation, invasion and apoptosis
- (2018) Ning Yu et al. PATHOLOGY RESEARCH AND PRACTICE
- Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers
- (2018) Yuxuan Wang et al. Science Translational Medicine
- PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells
- (2018) Otto Kauko et al. Science Translational Medicine
- Pharmacologic inhibition of protein phosphatase-2A achieves durable immune-mediated antitumor activity when combined with PD-1 blockade
- (2018) Winson S. Ho et al. Nature Communications
- A stable association with PME-1 may be dispensable for PP2A demethylation: Implications for the detection of PP2A methylation and immunoprecipitation
- (2018) Ryotaro Yabe et al. FEBS Open Bio
- Protein Phosphatase 2A in the Regulation of Wnt Signaling, Stem Cells, and Cancer
- (2018) Joshua Thompson et al. Genes
- mTOR Cross-Talk in Cancer and Potential for Combination Therapy
- (2018) Fabiana Conciatori et al. Cancers
- Targeting PP2A in cancer: Combination therapies
- (2018) Sahar Mazhar et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Targeted therapies don't work for a reason; the neglected tumor suppressor phosphatase PP2A strikes back
- (2018) Jukka Westermarck FEBS Journal
- Targeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too Late
- (2018) Michiel Remmerie et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology
- (2018) Laura Muinelo-Romay et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Prognostic significance of CIP2A expression in solid tumors: A meta-analysis
- (2018) Min Tang et al. PLoS One
- Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma
- (2018) Brittany L. Allen-Petersen et al. CANCER RESEARCH
- The red wine component ellagic acid induces autophagy and exhibits anti-lung cancer activity in vitro and in vivo
- (2018) Jing Duan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Targeted next-generation sequencing of endometrial cancer and matched circulating tumor DNA: identification of plasma-based, tumor-associated mutations in early stage patients
- (2018) Ana M. Bolivar et al. MODERN PATHOLOGY
- Cancerous inhibitor of protein phosphatase 2A regulates cisplatin resistance in ovarian cancer
- (2018) Wanbin Li et al. Oncology Letters
- Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines
- (2018) Eniko Papp et al. Cell Reports
- EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells
- (2017) Chun-Yu Liu et al. EUROPEAN JOURNAL OF CANCER
- The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review)
- (2017) Fatima Ardito et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Identification of PP2A/Set Binding Sites and Design of Interacting Peptides with Potential Clinical Applications
- (2017) Lu Tian et al. International Journal of Peptide Research and Therapeutics
- Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth
- (2017) Jaya Sangodkar et al. JOURNAL OF CLINICAL INVESTIGATION
- The genetic landscape of endometrial clear cell carcinomas
- (2017) Deborah F DeLair et al. JOURNAL OF PATHOLOGY
- Loss of protein phosphatase 2A regulatory subunit B56δ promotes spontaneous tumorigenesis in vivo
- (2017) C Lambrecht et al. ONCOGENE
- Arctigenin inhibits triple-negative breast cancers by targeting CIP2A to reactivate protein phosphatase 2A
- (2017) Qiuyue Huang et al. ONCOLOGY REPORTS
- A pathology atlas of the human cancer transcriptome
- (2017) Mathias Uhlen et al. SCIENCE
- Genomics and evolution of protein phosphatases
- (2017) Mark J. Chen et al. Science Signaling
- Activation of cancerous inhibitor of PP2A (CIP2A) contributes to lapatinib resistance through induction of CIP2A-Akt feedback loop in ErbB2-positive breast cancer cells
- (2017) Ming Zhao et al. Oncotarget
- 3D clusters of somatic mutations in cancer reveal numerous rare mutations as functional targets
- (2017) Jianjiong Gao et al. Genome Medicine
- Genomics and evolution of protein phosphatases
- (2017) Mark J. Chen et al. Science Signaling
- New Approaches to Difficult Drug Targets: The Phosphatase Story
- (2017) John S. Lazo et al. SLAS Discovery
- CIP2A expression is elevated in cervical cancer
- (2017) Lisa P. Huang et al. Cancer Biomarkers
- Regulation of protein phosphatase 2A (PP2A) tumor suppressor function by PME-1
- (2016) A. Kaur et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Recurrent PPP2R1A Mutations in Uterine Cancer Act through a Dominant-Negative Mechanism to Promote Malignant Cell Growth
- (2016) Dorien Haesen et al. CANCER RESEARCH
- PP2A Inhibitor PME-1 Drives Kinase Inhibitor Resistance in Glioma Cells
- (2016) Amanpreet Kaur et al. CANCER RESEARCH
- Safety, Tolerability, and Preliminary Activity of LB-100, an Inhibitor of Protein Phosphatase 2A, in Patients with Relapsed Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I Trial
- (2016) Vincent Chung et al. CLINICAL CANCER RESEARCH
- PP2A as a master regulator of the cell cycle
- (2016) Nathan Wlodarchak et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Genistein targets the cancerous inhibitor of PP2A to induce growth inhibition and apoptosis in breast cancer cells
- (2016) Qingxia Zhao et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis
- (2016) William J Gibson et al. NATURE GENETICS
- COSMIC: somatic cancer genetics at high-resolution
- (2016) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Gambogenic acid induces proteasomal degradation of CIP2A and sensitizes hepatocellular carcinoma to anticancer agents
- (2016) Xian-Jun Yu et al. ONCOLOGY REPORTS
- Long-Term Secondary Care Costs of Endometrial Cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
- (2016) Mark Pennington et al. PLoS One
- Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options
- (2016) Godfrey Grech et al. TUMOR BIOLOGY
- Inhibition of protein methylesterase 1 decreased cancerous phenotypes in endometrial adenocarcinoma cell lines and xenograft tumor models
- (2016) Michelle Pusey et al. TUMOR BIOLOGY
- Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors
- (2016) Amanda M. Smith et al. Oncotarget
- Patient derived mutation W257G of PPP2R1A enhances cancer cell migration through SRC-JNK-c-Jun pathway
- (2016) Ae Lee Jeong et al. Scientific Reports
- Endometrial Carcinoma
- (2015) Tatiana N. Buhtoiarova et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Reengineered tricyclic anti-cancer agents
- (2015) David B. Kastrinsky et al. BIOORGANIC & MEDICINAL CHEMISTRY
- PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas
- (2015) Jonathan D Black et al. BRITISH JOURNAL OF CANCER
- A note from history: Landmarks in history of cancer, part 7
- (2015) Steven I. Hajdu et al. CANCER
- LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential
- (2015) Christopher S Hong et al. CANCER BIOLOGY & THERAPY
- CIP2A cooperates with H-Ras to promote epithelial–mesenchymal transition in cervical-cancer progression
- (2015) Yi Wu et al. CANCER LETTERS
- All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase
- (2015) Jaya Sangodkar et al. FEBS Journal
- Targeted mutation analysis of endometrial clear cell carcinoma
- (2015) Lien N Hoang et al. HISTOPATHOLOGY
- Clinical significance of cancerous inhibitor of protein phosphatase 2A in human cancers
- (2015) Anchit Khanna et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer of the corpus uteri
- (2015) Frédéric Amant et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Fusogenic-oligoarginine peptide-mediated silencing of the CIP2A oncogene suppresses oral cancer tumor growth in vivo
- (2015) Angela A. Alexander-Bryant et al. JOURNAL OF CONTROLLED RELEASE
- Durability of Kinase-Directed Therapies--A Network Perspective on Response and Resistance
- (2015) B. W. Murray et al. MOLECULAR CANCER THERAPEUTICS
- Dual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo
- (2015) S. Lopez et al. MOLECULAR CANCER THERAPEUTICS
- Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity
- (2015) Matthew T Chang et al. NATURE BIOTECHNOLOGY
- Comprehensive assessment of cancer missense mutation clustering in protein structures
- (2015) Atanas Kamburov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of phosphoproteomics in the development of personalized cancer therapies
- (2015) Pedro R. Cutillas Proteomics Clinical Applications
- CIP2A is associated with multidrug resistance in cervical adenocarcinoma by a P-glycoprotein pathway
- (2015) Juan Liu et al. TUMOR BIOLOGY
- Regulation of the Wnt/β-Catenin Signaling Pathway by Human Papillomavirus E6 and E7 Oncoproteins
- (2015) Jesus Bello et al. Viruses-Basel
- SET antagonist enhances the chemosensitivity of non-small cell lung cancer cells by reactivating protein phosphatase 2A
- (2015) Man-Hsin Hung et al. Oncotarget
- PP2A inhibitors arrest G2/M transition through JNK/Sp1- dependent down-regulation of CDK1 and autophagy-dependent up-regulation of p21
- (2015) Fei-Ran Gong et al. Oncotarget
- PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects
- (2015) Raúl Rincón et al. Oncotarget
- Cancerous inhibitor of protein phosphatase 2A contributes to human papillomavirus oncoprotein E7-induced cell proliferation via E2F1
- (2015) Weifang Zhang et al. Oncotarget
- Precise Classification of Cervical Carcinomas Combined with Somatic Mutation Profiling Contributes to Predicting Disease Outcome
- (2015) Vivian M. Spaans et al. PLoS One
- Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): an oncoprotein with many hands
- (2015) Pradip De et al. Oncotarget
- Arsenic Trioxide Inhibits CXCR4-Mediated Metastasis by Interfering miR-520h/PP2A/NF-κB Signaling in Cervical Cancer
- (2014) Yi-Wen Chang et al. ANNALS OF SURGICAL ONCOLOGY
- ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
- (2014) Carlos L. Arteaga et al. CANCER CELL
- PME-1 Modulates Protein Phosphatase 2A Activity to Promote the Malignant Phenotype of Endometrial Cancer Cells
- (2014) E. Wandzioch et al. CANCER RESEARCH
- Deregulation of the PP2A Inhibitor SET Shows Promising Therapeutic Implications and Determines Poor Clinical Outcome in Patients with Metastatic Colorectal Cancer
- (2014) I. Cristobal et al. CLINICAL CANCER RESEARCH
- Antagonism of SET Using OP449 Enhances the Efficacy of Tyrosine Kinase Inhibitors and Overcomes Drug Resistance in Myeloid Leukemia
- (2014) A. Agarwal et al. CLINICAL CANCER RESEARCH
- FTY720 and cisplatin synergistically induce the death of cisplatin-resistant melanoma cells through the downregulation of the PI3K pathway and the decrease in epidermal growth factor receptor expression
- (2014) ASAKO ISHITSUKA et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- CIP2A oncoprotein controls cell growth and autophagy through mTORC1 activation
- (2014) Pietri Puustinen et al. JOURNAL OF CELL BIOLOGY
- Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia
- (2014) Alejandro Gutierrez et al. JOURNAL OF CLINICAL INVESTIGATION
- Papillomavirus E7 Oncoproteins Share Functions with Polyomavirus Small T Antigens
- (2014) Elizabeth A. White et al. JOURNAL OF VIROLOGY
- CIP2A mediates erlotinib-induced apoptosis in non-small cell lung cancer cells without EGFR mutation
- (2014) Cheng-Yi Wang et al. LUNG CANCER
- Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer
- (2014) Lorena Alonso-Alconada et al. Molecular Cancer
- Stable SET knockdown in head and neck squamous cell carcinoma promotes cell invasion and the mesenchymal-like phenotype in vitro, as well as necrosis, cisplatin sensitivity and lymph node metastasis in xenograft tumor models
- (2014) Lays M Sobral et al. Molecular Cancer
- The Protein Phosphatase 2A Inhibitor LB100 Sensitizes Ovarian Carcinoma Cells to Cisplatin-Mediated Cytotoxicity
- (2014) K.-E. Chang et al. MOLECULAR CANCER THERAPEUTICS
- Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer
- (2014) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Designing a High-Throughput Somatic Mutation Profiling Panel Specifically for Gynaecological Cancers
- (2014) Vivian M. Spaans et al. PLoS One
- Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis
- (2014) Xinxin Liu et al. TUMOR BIOLOGY
- Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2A
- (2014) H-C Yu et al. Cell Death & Disease
- The Basic Biology of PP2A in Hematologic Cells and Malignancies
- (2014) Dorien Haesen et al. Frontiers in Oncology
- Protein tyrosine phosphatases as novel targets in breast cancer therapy
- (2013) Caroline E. Nunes-Xavier et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer
- (2013) Parthasarathy Seshacharyulu et al. CANCER LETTERS
- Chk1 Targeting Reactivates PP2A Tumor Suppressor Activity in Cancer Cells
- (2013) A. Khanna et al. CANCER RESEARCH
- Cancerous inhibitor of PP2A is targeted by natural compound celastrol for degradation in non-small-cell lung cancer
- (2013) Zi Liu et al. CARCINOGENESIS
- Estradiol enhances CIP2A expression by the activation of p70 S6 kinase
- (2013) Yeon A Choi et al. ENDOCRINE-RELATED CANCER
- Cost information of chemotherapy for cervical and endometrial cancer in Japan
- (2013) Yuko Kamijo et al. Japan Journal of Nursing Science
- Validation of a Next-Generation Sequencing Assay for Clinical Molecular Oncology
- (2013) Catherine E. Cottrell et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Protein phosphatase 2A: a target for anticancer therapy
- (2013) Danilo Perrotti et al. LANCET ONCOLOGY
- Infrequent mutations of the PPP2R1A and PPP2R1B genes in patients with ovarian cancer
- (2013) FENG WANG et al. Molecular Medicine Reports
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Landscape of genomic alterations in cervical carcinomas
- (2013) Akinyemi I. Ojesina et al. NATURE
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- Fusogenic-Oligoarginine Peptide-Mediated Delivery of siRNAs Targeting the CIP2A Oncogene into Oral Cancer Cells
- (2013) Liliana Cantini et al. PLoS One
- Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma
- (2013) S. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Ethoxysanguinarine Induces Inhibitory Effects and Downregulates CIP2A in Lung Cancer Cells
- (2013) Zi Liu et al. ACS Medicinal Chemistry Letters
- The Role and Therapeutic Potential of Ser/Thr Phosphatase PP2A in Apoptotic Signalling Networks in Human Cancer Cells
- (2012) V. Janssens et al. CURRENT MOLECULAR MEDICINE
- Protein Ser/ Thr phosphatases - the ugly ducklings of cell signalling
- (2012) David L. Brautigan FEBS Journal
- PP1 and PP2A phosphatases - cooperating partners in modulating retinoblastoma protein activation
- (2012) Victoria Kolupaeva et al. FEBS Journal
- The human phosphatase interactome: An intricate family portrait
- (2012) Francesca Sacco et al. FEBS LETTERS
- Lapatinib and potential prognostic value of EGFR mutations in a Gynecologic Oncology Group phase II trial of persistent or recurrent endometrial cancer
- (2012) Kimberly K. Leslie et al. GYNECOLOGIC ONCOLOGY
- Use of mutation profiles to refine the classification of endometrial carcinomas
- (2012) Melissa K McConechy et al. JOURNAL OF PATHOLOGY
- Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses
- (2012) Elisabetta Kuhn et al. JNCI-Journal of the National Cancer Institute
- Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes
- (2012) Matthieu Le Gallo et al. NATURE GENETICS
- CIP2A-mediated Akt activation plays a role in bortezomib-induced apoptosis in head and neck squamous cell carcinoma cells
- (2012) Yu-Chin Lin et al. ORAL ONCOLOGY
- CIP2A is overexpressed in human ovarian cancer and regulates cell proliferation and apoptosis
- (2012) Yuanyuan Fang et al. TUMOR BIOLOGY
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Somatic Mutations of PPP2R1A in Ovarian and Uterine Carcinomas
- (2011) Ie-Ming Shih et al. AMERICAN JOURNAL OF PATHOLOGY
- Prognostic role of CIP2A expression in serous ovarian cancer
- (2011) C Böckelman et al. BRITISH JOURNAL OF CANCER
- Development of targeted therapy in uterine serous carcinoma, a biologically aggressive variant of endometrial cancer
- (2011) Karim S El-Sahwi et al. Expert Review of Anticancer Therapy
- Increase in CIP2A expression is associated with doxorubicin resistance
- (2011) Yeon A. Choi et al. FEBS LETTERS
- Cancerous inhibitor of protein phosphatase 2A is overexpressed in cervical cancer and upregulated by human papillomavirus 16 E7 oncoprotein
- (2011) Juan Liu et al. GYNECOLOGIC ONCOLOGY
- Discovery and Optimization of Sulfonyl Acrylonitriles as Selective, Covalent Inhibitors of Protein Phosphatase Methylesterase-1
- (2011) Daniel A. Bachovchin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Robotic-assisted surgery in the management of endometrial cancer
- (2011) Robert W. Holloway et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas
- (2011) Melissa K McConechy et al. JOURNAL OF PATHOLOGY
- Low-grade serous carcinomas of the ovary contain very few point mutations
- (2011) Siân Jones et al. JOURNAL OF PATHOLOGY
- Human Cancer-Associated Mutations in the A Subunit of Protein Phosphatase 2A Increase Lung Cancer Incidence in A Knock-In and Knockout Mice
- (2011) R. Ruediger et al. MOLECULAR AND CELLULAR BIOLOGY
- PPP2R1A mutations are common in the serous type of endometrial cancer
- (2011) Deepak C. Nagendra et al. MOLECULAR CARCINOGENESIS
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overexpression and Small Molecule-Triggered Downregulation of CIP2A in Lung Cancer
- (2011) Liang Ma et al. PLoS One
- Academic cross-fertilization by public screening yields a remarkable class of protein phosphatase methylesterase-1 inhibitors
- (2011) D. A. Bachovchin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
- (2011) Michelle C. Mendoza et al. TRENDS IN BIOCHEMICAL SCIENCES
- Assessment of the Evolution of Cancer Treatment Therapies
- (2011) Manuel Arruebo et al. Cancers
- Identification of PP2A Complexes and Pathways Involved in Cell Transformation
- (2010) A. A. Sablina et al. CANCER RESEARCH
- Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer–Results from two randomised studies
- (2010) Thomas Hogberg et al. EUROPEAN JOURNAL OF CANCER
- Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis
- (2010) Luis Paz-Ares et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review
- (2010) Xin An et al. LEUKEMIA RESEARCH
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells
- (2010) K-F Chen et al. ONCOGENE
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
- (2010) Siân Jones et al. SCIENCE
- PME-1 Protects Extracellular Signal-Regulated Kinase Pathway Activity from Protein Phosphatase 2A-Mediated Inactivation in Human Malignant Glioma
- (2009) P. Puustinen et al. CANCER RESEARCH
- Serine/Threonine Phosphatases: Mechanism through Structure
- (2009) Yigong Shi CELL
- CIP2A Is Associated with Human Breast Cancer Aggressivity
- (2009) C. Come et al. CLINICAL CANCER RESEARCH
- Synuclein-γ (SNCG) may be a novel prognostic biomarker in uterine papillary serous carcinoma
- (2009) Jacqueline Morgan et al. GYNECOLOGIC ONCOLOGY
- Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study
- (2009) Gini F. Fleming et al. GYNECOLOGIC ONCOLOGY
- Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms
- (2009) Jie Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Spatial control of protein phosphatase 2A (de)methylation
- (2007) Sari Longin et al. EXPERIMENTAL CELL RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started